| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GT Biopharma, Inc. | Director | Option to purchase Common Stock | 500,000 | 27 Jan 2023 | Direct | ||
| CASI Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 345,806 | 25 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GTBP | GT Biopharma, Inc. | 27 Jan 2023 | 1 | $0 | 4 | Director | 01 Feb 2023, 05:02 |
| GTBP | GT Biopharma, Inc. | 15 Jul 2022 | 3 | $0 | 4 | Director | 19 Jul 2022, 21:46 |
| /report/000110465922065264-shrotriya-rajesh-c-md-2022-05-25 | CASI Pharmaceuticals, Inc. | 25 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 16:11 |
| /report/000110465921081993-shrotriya-rajesh-c-md-2021-06-15 | CASI Pharmaceuticals, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 16:02 |
| GTBP | GT Biopharma, Inc. | 16 Feb 2021 | 1 | $0 | 4 | Director | 14 Feb 2022, 15:13 |
| GTBP | GT Biopharma, Inc. | 13 Jan 2021 | 0 | $0 | 3 | Director | 14 Feb 2022, 15:00 |